© 2025 TCG Labs Soleil. All rights reserved.
Scroll
a
TCG LABS SOLEIL
A New Model for
An Integrated Venture-
Biotech R&D Ecosystem
Latest News

At TCG Labs Soleil, we are establishing a pioneering venture- biotech model in collaboration with The Column Group.

Our approach integrates a dedicated venture fund (TCG Labs) with an evergreen R&D hub led by top-tier scientists (Soleil). This creates a powerful ecosystem forming and overseeing independent portfolio companies, each dedicated to single-asset programs, guiding them from ideation to clinical proof of concept and positioning them for strategic partnerships and transformative medical advancements.

To efficiently
translate scientific
insights into therapeutic solutions for patients
facing serious diseases.

To efficiently translate scientific insights into therapeutic solutions for patients facing serious diseases.

How it works

Exclusively Funds, Discovers & Develops Single-Asset Therapies Poised for Strategic Transactions

If your organization prioritizes speed, efficiency, and risk mitigation in the drug development process, our single-asset programs provide a tailored solution. Ideal for entities aiming to expedite the journey from concept to commercialization, our model offers vetted assets ready for efficient adoption and development.
If you are a scientific leader with innovative ideas that could transform into therapeutic solutions, partner with TCG Labs Soleil. We unite your visionary concepts with our comprehensive expertise to drug discovery for patients facing serious diseases.

Targeted Selection

Identify assets that align with your strategic goals from our portfolio. Each asset is backed by human proof of concept data, ensuring a high degree of de-risking and readiness for late-stage development.

Efficient Integration

Leverage our 'plug and play' model for seamless incorporation of these assets into your pipeline. This approach is designed to simplify the transition into your existing development processes, facilitating a rapid progression through to market readiness.

Strategic Expansion

Expand your portfolio with high-potential, single-asset programs that span therapeutic areas including oncology and autoimmune diseases. Our disciplined approach to innovation ensures that each asset is not only scientifically sound but also strategically adaptable.

Accelerated Development

Accelerate your development timeline with assets that are primed for late-stage trials. Our model cuts through early-stage complexities, offering a direct path to clinical validation and market entry.

Market Transformation

Transform patient care by introducing potentially new treatments to the market more swiftly.

Initiate Collaboration

Present your promising ideas to TCG Labs Soleil.

Resource Allocation

Access dedicated capital and work with our elite drug discovery team to develop your idea into a human proof of concept.

Company Formation

We establish an independent portfolio company around your asset providing the operational infrastructure so you can continue to offer scientific insights and collaborate with our seasoned drug developers.

Accelerated Development

Experience a streamlined development process designed for rapid progress and significant impact, while maintaining an undiluted ownership stake.

Strategic Positioning

Ready your asset for a strategic transaction, positioning it for seamless integration into late-stage development pipelines.

Explore the Multifaceted Advantages of Our Model

Efficient R&D

We offer scientific founders access to an established top-tier drug discovery team and dedicated funding from idea to application.

Focused Approach

We form and oversee portfolio companies for single-asset programs, focusing on efficient drug development from idea to clinical validation, reducing complicated financing needs and avoiding typical biotech hurdles.

Simple Transactions

We facilitate flexible, strategic transactions each backed by human proof of concept and primed for integration into late-stage development pipelines.

One Lab, One Team

Our differentiated model fosters an evergreen team enabling continuity and productivity so we can concentrate on what we do best – innovative drug development, ensuring undiluted focus on our mission.
Learn how you can get
started with our ecosystem
Learn how
you can get started with our ecosystem
Learn More